659P Combination treatment with TTX-030, a first-in-class anti-CD39 antibody, in patients with advanced pancreatic cancer von Wainberg, Z.A., Cha, Y., George, B., Grewal, J.S., Merchan, J.R., Mckean, M., Soares, H.P., Cruz, T.D., Moesta, A.K., Jahn, T.M., Singhal, A.K., Tribouley, C., Kongpachith, S., Afar, D.E., Mitra, S., Spigel, D.R., Balaraman, R.

Volltext

TIK, a novel serine/threonine kinase, is recognized by antibodies directed against phosphotyrosine von ICELY, P. L, GROS, P, BERGERON, J. J. M, DEVAULT, A, AFAR, D. E. H, BELL, J. C

Volltext